Archives: Speakers

Rupi Bancil is the Senior Vice President, Global Study Operations & Global Expansion at Care Access. She started her career at PAREXEL and then moved to Synexus Clinical Research (later part of PPD), where she led site operations, feasibility, project management, operational compliance, and global patient recruitment teams. Rupi is passionate about using patient-centric approaches to make research more accessible to diverse communities around the world. She holds a Bachelor of Science degree in Biomedical Sciences from Brunel University London.

Rebecca Clancy is a Presales Insurance Solutions Consultant at Appian, where her focus lies in fostering collaborative partnerships with insurance firms. Through her role, Rebecca works closely with clients to explore how the Appian platform can effectively automate and streamline their processes. With a passion for problem-solving and her understanding of industry dynamics, Rebecca works to deliver tailored solutions that drive efficiency and enhance operational effectiveness, helping accelerate their digital transformation journey by maximising the benefits of the platform.

As a speaker at the Digital Transformation in Insurance Conference, she shares an insight into how innovative technology can drive operational efficacy within the insurance sector, shaping the future of intelligent claims handling in an ever evolving digital landscape.

Sas Maheswaran is a clinical operations leader with more than 17 years of experience. He incorporates unique perspectives gained from his time working at sponsors, sites, and software vendors to formulate practical approaches to digital transformation, including in the adoption of AI driven solutions in Clinical Development. In his current role as Vice President of Product Implementation at Saama Technologies, Sas is responsible for ensuring that sponsors and CRO partners are optimally utilizing Saama’s industry leading AI capabilities.

Lakshmi is a seasoned professional with an impressive 16-year tenure in the pharmaceutical, biotech, and CRO industries. With over a decade of global project management experience, she excels in leading cross-functional teams and managing the intricate balance between operational demands and financial constraints to successfully execute programs from inception to completion. Her extensive knowledge spans all trial phases across various global markets, including APAC, Europe and North America. Lakshmi’s experience spans several therapeutic areas, including gene therapy, rare diseases, respiratory, chronic inflammation, immunology, oncology, dermatology, CVM, and endocrinology.

MarieElena has been active in both research and clinical care through her career.  She brings more than ten years of leadership experience in clinical research sites management to the Worldwide team. She is also a clinically active nurse practitioner with more than 17 years of experience and a specialty in endocrinology. She has served as principal and sub-investigator for cardiometabolic trials and holds publications in peer-reviewed and high-impact journals. She is passionate about bringing her understanding of the patient journey to the Worldwide team.

Kelly has over 25 years of experience in obtaining and discerning the patient and caregiver experience as well as developing strong relationships with advocacy groups on a global scale. She has extensive experience in multiple therapeutic areas such as oncology, cardiovascular, endocrinology, orthopedics, infectious disease, neurology, pediatrics, and critical care. This depth and breadth of experience translate into a keen understanding of how patients think regarding their treatment giving her a singular perspective on the best way to approach patients with their treatment options, and an understanding that proves invaluable to her pharmaceutical and clinical research stakeholders.

Aki Ko has served as Chief Executive Officer and Chair of the Board of Directors since May 2017, when he co-founded the company. Previously, Mr. Ko served as Chief Operating Officer for Elixirgen, LLC, the parent company of Elixirgen Therapeutics, and President of Elixirgen Scientific, LLC, a provider of stem cell reagent kits and related services. In his previous roles, Mr. Ko was responsible for operations and business development at Elixirgen, LLC and Elixirgen Scientific. Mr. Ko earned a Bachelor of Science degree from the University of Virginia, where he cultivated his interest in biology.